Related Experiment Video
Updated: Apr 12, 2026

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
Published on: May 10, 2020
Hypomagnesemia and isoproterenol cardiomyopathies: Protection by probucol
A H Atrakchi1, S Bloom2, B F Dickens1
1Division of Experimental Medicine, The George Washington Medical Center, Washington, D.C., USA.
Insights
Chronic magnesium deficiency causes heart damage, potentially via free radicals. The antioxidant probucol protected against this damage, suggesting free radicals contribute to magnesium deficiency-induced heart injury.
Area of Science:
- Cardiology
- Biochemistry
- Pathology
Background:
- Chronic magnesium deficiency is linked to damage in cardiac, vascular, and neuronal tissues.
- The precise mechanisms underlying magnesium deficiency-induced damage are not fully understood.
- Previous studies suggest a role for free radicals in magnesium deficiency-related myocardial necrosis.
Purpose of the Study:
- To investigate the hypothesis that free-radical damage contributes to magnesium deficiency-induced myocardial necrosis.
- To evaluate the protective effects of probucol, an antioxidant agent, against cardiac injury in magnesium-deficient hamsters.
Main Methods:
- Hamsters were fed a magnesium-deficient diet for 14 days, with or without probucol.
- Animals received isoproterenol injections to induce cardiac stress.
- Cardiac lesions were analyzed morphometrically, and serum lipid levels were measured.
Main Results:
- Probucol significantly reduced the size and number of cardiac lesions induced by both isoproterenol and magnesium deficiency.
- The protective effect of probucol was attributed to its antioxidant properties, not its lipid-lowering effects.
- Serum lipid profiles were also assessed in the study.
Conclusions:
- Free-radical damage likely plays a significant role in magnesium deficiency-induced myocardial necrosis.
- Probucol's antioxidant activity offers protection against cardiac injury associated with magnesium deficiency.
- These findings highlight the importance of antioxidant strategies in managing magnesium deficiency-related cardiovascular complications.
Abstract:
Chronic magnesium deficiency is associated with injury of heart muscle, blood vessels, and neuronal tissue. Despite its clinical significance, the mechanism of magnesium deficiency-induced damage remains unclear. The myocardial necrosis induced by injecting catecholamines, which is augmented by magnesium deficiency, is thought to involve a free radical component through catecholamine autoxidation. α-tocopherol was shown to ameliorate the myocardial necrosis induced by magnesium-deficiency (Freedman et al. BBRC 1990;170:1102-1106), suggesting a role for free radicals in this process. If free-radical injury plays a role in magnesium deficiency, then the catecholamine-associated free-radical production may explain the synergistic myocardial injury between catecholamine and magnesium deficiency. To test the hypothesis that free-radical damage may play a role in magnesium deficiency-induced myocardial necrosis, we investigated the protective effects of probucol, a hypolipidemic agent with antioxidant properties. Hamsters were fed a Mg-deficient diet for 14 days with or without probucol. At the end of this period, some animals were sacrificed, while others were injected with isoproterenol and killed 48 hours later. All hearts were processed for morphometric analysis of the lesions. Changes in serum lipids were also determined. Probucol reduced the size and number of both the isoproterenol- and magnesium deficiency-induced cardiac lesions. Our results suggest that it is probucol's antioxidant property and not its hypolipidemic action that is responsible for this protection.
More Related Videos
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy